|
|
| Cervical Cancer |
|
Free Subscription
1 Adv Sci (Weinh) |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Cervical Cancer is free of charge.
Deep Learning-Enhanced Hand-Driven Microfluidic Chip for Multiplexed Nucleic Acid
Detection Based on RPA/CRISPR.
Adv Sci (Weinh). 2025;12:e2414918.
PubMed
Abstract available
Emergency Radiation Therapy for Hemorrhage in Botryoides Sarcoma: A Pediatric
Case Report.
Am J Case Rep. 2025;26:e946434.
PubMed
Abstract available
Prevalence of Human Papillomavirus and Genotype Correlation with Cervical Lesions
at the University Teaching Hospital of Kigali.
Am J Trop Med Hyg. 2025;112:1335-1340.
PubMed
Abstract available
ASO Author Reflections: Multi-omic and Single-Cell Insights into the Age-Related
Molecular Landscape of Cervical Cancer.
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17543.
PubMed
APG-115 synergizes with bortezomib to induce apoptosis in cervical cancer cells.
Anticancer Drugs. 2025 Jun 3. doi: 10.1097/CAD.0000000000001735.
PubMed
Abstract available
Significance of PFKFB4 and gene risk signature in cervical cancer prognosis and
progression.
Biochem Biophys Res Commun. 2025;775:152084.
PubMed
Abstract available
Deregulation of LIMD1-VHL-HIF-1alpha-VEGF pathway is associated with different stages
of cervical cancer.
Biochem J. 2025;482:BCJ20170649.
PubMed
Biochim Biophys Acta Mol Cell Res
Metabolomic profiling reveals grade-specific niacinamide accumulation and its
therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer
progression.
Biochim Biophys Acta Mol Cell Res. 2025;1872:119994.
PubMed
Abstract available
Design, synthesis, and in vitro and in vivo anti-drug resistant cervical cancer
activity of novel licochalcone A derivatives based on dual targeting of
VEGFR-2/P-gp.
Bioorg Chem. 2025;163:108639.
PubMed
Abstract available
Topical imiquimod treatment of residual or recurrent cervical intraepithelial
neoplasia lesions (TOPIC-2): A randomised controlled trial.
BJOG. 2025;132:1056-1064.
PubMed
Abstract available
High-risk human papillomavirus testing in first-void urine as a novel and
non-invasive cervical cancer screening modality-a Danish diagnostic test accuracy
study.
BMC Med. 2025;23:327.
PubMed
Abstract available
Sociocultural factors influencing women's adherence to colorectal, breast, and
cervical cancer screening: a systematic review.
BMC Public Health. 2025;25:2034.
PubMed
Abstract available
Postnatal instead of normally-timed cervical screening (PINCS-1): a protocol for
a feasibility study of paired-sample cervical screening and urine self-sampling
at 6 weeks and 12 weeks postnatal in the UK.
BMJ Open. 2025;15:e092701.
PubMed
Abstract available
Impact of an educational physiotherapy-yoga intervention on perceived stress in
women treated with brachytherapy for cervical cancer: a randomised controlled
mixed study protocol (KYOCOL).
BMJ Open. 2025;15:e098570.
PubMed
Abstract available
Stakeholder perspectives on HPV vaccination uptake among Aboriginal and Torres
Strait Islander adolescents via the school immunisation programmes in Queensland:
a qualitative study.
BMJ Open. 2025;15:e097518.
PubMed
Abstract available
The American Brachytherapy Society (ABS) consensus guidance for hybrid
intracavitary interstitial brachytherapy for locally advanced cervical cancer.
Brachytherapy. 2025 May 29:S1538-4721(25)00086.
PubMed
Abstract available
Interplay between human papillomavirus infection, cervical cancer history, and
the incidence of oral cancer: A cohort study.
Cancer Epidemiol. 2025;97:102858.
PubMed
Abstract available
Burden of cervical cancer in Martinique, 2012-2021.
Cancer Epidemiol. 2025;97:102857.
PubMed
Abstract available
Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in
cervical precancerous lesions.
Cancer Genet. 2025;294-295:99-110.
PubMed
Abstract available
Single-cell RNA sequencing analysis reveals a lack of CXCL13(+) T cell subsets
associated with the recurrence of cervical squamous cell carcinoma following
concurrent chemoradiotherapy.
Cancer Immunol Immunother. 2025;74:235.
PubMed
Abstract available
Corrigendum to "METTL3-mediated HSPA9 m6A modification promotes malignant
transformation and inhibits cellular senescence by regulating exosomal mortalin
protein in cervical cancer" [Cancer Lett. 587 (2024) 216658].
Cancer Lett. 2025 Jun 3:217827. doi: 10.1016/j.canlet.2025.217827.
PubMed
Commentary on the "Relationship between visceral obesity and prognosis in
patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy".
Cancer Pathog Ther. 2025;3:269-270.
PubMed
Insights on the prognostic value of visceral obesity in stage IVB cervical cancer
treatment.
Cancer Pathog Ther. 2025;3:267-268.
PubMed
Changes of Microbiome in Human Papillomavirus Infection and Cervical Cancer: A
Systematic Review and Meta-Analysis.
Cancer Rep (Hoboken). 2025;8:e70246.
PubMed
Abstract available
ChatGPT SMART Goals for collaborative practices in the Global Strategy to
Accelerate the Elimination of Cervical Cancer.
Cien Saude Colet. 2025;30:e00662025.
PubMed
Abstract available
Cellular Immune Response to High-Risk Human Papillomavirus Infection: A
Systematic Review.
Crit Rev Immunol. 2025;45:33-49.
PubMed
Abstract available
Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Cervical
Cancer (SCORE): a Systematic Review and Meta-analysis.
Crit Rev Oncol Hematol. 2025 Jun 1:104789. doi: 10.1016/j.critrevonc.2025.104789
PubMed
Abstract available
Investigation of Dosimetric Evaluation and Treatment Planning Time of Inverse
Planning Optimization in Combined Intracavitary and Interstitial Brachytherapy
for Cervical Cancer.
Cureus. 2025;17:e83330.
PubMed
Abstract available
Comprehensive Pan-cancer Analysis and Experimental Verification of EGLN Family:
Potential Biomarkers in Cervical Cancer.
Curr Cancer Drug Targets. 2025 Jun 3. doi: 10.2174/0115680096362252250527060004.
PubMed
Abstract available
Determination of Prevalence and Genotype Distribution of High-Risk Human
Papillomavirus in Varamin (Iran).
Diagn Cytopathol. 2025;53:325-332.
PubMed
Abstract available
Human Papillomavirus Prevalence and Genotype Distribution Among Women With
Cervical Cytological Abnormalities in Urumqi, Xinjiang, China.
Diagn Cytopathol. 2025;53:315-324.
PubMed
Abstract available
Identification and validation of a thirteen-gene signature based on ubiquitin
related genes in cervical cancer.
Discov Oncol. 2025;16:1000.
PubMed
Abstract available
Demand-side barriers and economic burden in accessing Human Papillomavirus
screening for cervical cancer prevention in rural India: Evidence from a
cross-sectional study.
F1000Res. 2025;13:630.
PubMed
Abstract available
Osthole inhibits proliferation and induces autophagy-dependent ferroptosis of
cervical cancer cells through induction of TFR1.
Food Chem Toxicol. 2025;203:115577.
PubMed
Abstract available
Analysis of the correlation between RFC4 expression and tumor immune
microenvironment and prognosis in patients with cervical cancer.
Front Genet. 2025;16:1514383.
PubMed
Abstract available
Multi-omics analyses construct an inflammatory response based prognostic gene
signature for cervical cancer and suggest tumor infiltrating monocytes subgroups
as key players.
Front Immunol. 2025;16:1563593.
PubMed
Abstract available
Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer.
Front Immunol. 2025;16:1524842.
PubMed
Abstract available
Editorial: Cervical screening awareness week 2023: integrating cervical cancer
screening and precancer treatments.
Front Oncol. 2025;15:1614832.
PubMed
Innovative nomogram for cervical cancer prediction: integrating high-risk HPV
infection, p53 genotype, and blood routine parameters.
Front Oncol. 2025;15:1541928.
PubMed
Abstract available
The efficacy and safety of Tisotumab vedotin in the treatment of
recurrent/metastatic cervical cancer: a systematic review and meta-analysis of
single-arm studies.
Front Pharmacol. 2025;16:1538980.
PubMed
Abstract available
Study on the relationship between vaginal dose and radiation-induced vaginal
injury following cervical cancer radiotherapy, and model development.
Front Public Health. 2025;13:1585481.
PubMed
Abstract available
EXPERIENCE OF IMPLEMENTING DIGITAL TELEMEDICINE TECHNOLOGIES TO IMPROVE ACCESS TO
CERVICAL CANCER SCREENING IN RURAL AREAS OF THE REPUBLIC OF KAZAKHSTAN.
Georgian Med News. 2025;:187-194.
PubMed
Abstract available
Comparative Evaluation of Dosimetric Parameters in Carcinoma Cervix Patients
Undergoing Intensity-Modulated Radiotherapy versus Three-Dimensional
Radiotherapy: A Retrospective Analysis.
Gulf J Oncolog. 2025;1:7-12.
PubMed
Abstract available
Postoperative hypofractionated intensity-modulated radiation therapy in cervical
cancer: prospective phase 2 trial (POHIM_RT study).
Gynecol Oncol. 2025;198:84-89.
PubMed
Abstract available
Efficacy of digital educational intervention using I-Change model in promoting
preventive behaviors for cervical cancer among Iranian women: A randomized
controlled trial.
Health Promot Perspect. 2025;15:44-53.
PubMed
Abstract available
Male partner roles in cervical cancer transmission and prevention in central
Kenya: A quantitative approach.
Health SA. 2025;30:2858.
PubMed
Abstract available
Barriers associated with the parental acceptance of human papillomavirus (HPV)
vaccination of minors in Asir, Saudi Arabia: A cross-sectional study.
Hum Vaccin Immunother. 2025;21:2513708.
PubMed
Abstract available
Exploring the mechanism by which BXSD decoction treats cervical cancer through
the combination of network pharmacology and molecular docking analysis: Molecular
mechanism of AKT1 and CASP3 protein.
Int J Biol Macromol. 2025;317.
PubMed
Abstract available
High human papillomavirus viral load and local immune dysregulation are
associated with poor clinical outcomes in patients with cervical cancer.
Int J Gynecol Cancer. 2025;35:101924.
PubMed
Abstract available
Survival outcomes and safety of nimotuzumab combined with radiotherapy +/-
chemotherapy for locally advanced cervical cancer.
Int J Gynecol Cancer. 2025;35:101930.
PubMed
Abstract available
High HPV viral load predicts worse prognosis in patients with cervical cancer
treated with radiochemotherapy.
Int J Radiat Biol. 2025 Jun 2:1-14. doi: 10.1080/09553002.2025.2510668.
PubMed
Abstract available
Impact of patient selection on real-world outcomes by using the EMBRACE-II
treatment protocol in locally advanced cervical cancer.
Int J Radiat Oncol Biol Phys. 2025 Jun 1:S0360-3016(25)00554.
PubMed
Abstract available
Endocervical Adenocarcinoma With Micropapillary Component, a Distinct
Histological Subtype Associated With Aggressive Behavior and Poor Prognosis: A
Clinicopathologic Study of 10 Patients.
Int J Surg Pathol. 2025;33:801-808.
PubMed
Abstract available
The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with
Experimental Validation.
Int J Womens Health. 2025;17:1511-1532.
PubMed
Abstract available
Radiation Nephropathy Complicated by Tubulointerstitial Nephritis with
Predominantly Lymphocyte and Plasma Cell Infiltration.
Intern Med. 2025;64:1696-1705.
PubMed
Abstract available
Community-level Social Vulnerability and Cervical Cancer Mortality Among Young
and Old Adults in the State of Alabama.
J Community Health. 2025 Jun 1. doi: 10.1007/s10900-025-01482.
PubMed
Abstract available
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management
Guidelines.
J Gen Intern Med. 2025 May 30. doi: 10.1007/s11606-025-09611.
PubMed
Abstract available
Risk for Human Papillomavirus-Associated Gynecologic Cancers Among Women of
Childbearing Age With Rheumatic Diseases: A Population-Based Cohort Study.
J Korean Med Sci. 2025;40:e95.
PubMed
Abstract available
Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via
strengthening CD8 + TILs function and recruiting B cells in cervical cancer.
J Nanobiotechnology. 2025;23:413.
PubMed
Abstract available
RE: Invasive cervical cancer incidence following bivalent human papillomavirus
vaccination: a population-based observational study of age at immunization, dose,
and deprivation.
J Natl Cancer Inst. 2025 Jun 6:djaf130. doi: 10.1093.
PubMed
Association of Socio-Environmental Burden and Inequality With Cancer Screening
and Mortality.
J Surg Oncol. 2025;131:1110-1117.
PubMed
Abstract available
HPV Self-Collection for Cervical Cancer Screening-There's No Place Like Home.
JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2978.
PubMed
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The
PRESTIS Randomized Clinical Trial.
JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2971.
PubMed
Abstract available
Use of Thermal Ablation in Low-Resource Settings: Experience From Three
Multicenter Noninferiority Randomized Clinical Trials.
JCO Glob Oncol. 2025;11:e2500050.
PubMed
Abstract available
Age-related changes in the radiologic findings of lobular endocervical glandular
hyperplasia: a multicenter study.
Jpn J Radiol. 2025;43:985-994.
PubMed
Abstract available
Prevalence of Depression and Associated Factors among Cervical Cancer Patients
Attending Tertiary Center in Bhaktapur, Nepal.
Kathmandu Univ Med J (KUMJ). 2024;22:385-392.
PubMed
Abstract available
Community-based Screening of Cervical Cancer in an Urban Setting in Nepal: A
Cross-sectional Study.
Kathmandu Univ Med J (KUMJ). 2024;22:413-418.
PubMed
Abstract available
[Diagnosis, treatment and oncological outcome of cervical CUP-syndrome depending
on p16 status].
Laryngorhinootologie. 2025;104:361-370.
PubMed
Abstract available
Microbial and metabolic profiles associated with HPV infection and cervical
intraepithelial neoplasia: a multi-omics study.
Microbiol Spectr. 2025;13:e0019225.
PubMed
Abstract available
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response
Monitoring of Cervical Cancer.
Mol Diagn Ther. 2025 Jun 3. doi: 10.1007/s40291-025-00790.
PubMed
Abstract available
Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions
of the cervix through a targeted RNA next generation sequencing assay.
Mol Med. 2025;31:215.
PubMed
Abstract available
Development of an innovative approach for early diagnosis of cervical cancer
using TCR?like antibodies targeting HPV18 E6 and E7 peptides.
Mol Med Rep. 2025;32:218.
PubMed
Abstract available
Trends in cervical cancer screening modality in the active component U.S.
military, 2013-2023.
MSMR. 2025;32:14-18.
PubMed
Abstract available
Systemic Inflammatory Response Index in Cervical Pathologies (Human
Papillomavirus and Cervical Neoplasia) and its Prognostic Value in Disease
Prediction.
Niger J Clin Pract. 2025;28:615-623.
PubMed
Abstract available
PET for predicting chemoradiotherapy survival in cervical cancer: the search
continues.
Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999.
PubMed
Abstract available
Quantitative and automatic plan-of-the-day assessment to facilitate adaptive
radiotherapy in cervical cancer.
Phys Med Biol. 2025 Jun 5. doi: 10.1088/1361-6560.
PubMed
Abstract available
Computational investigation and experimental validation of the molecular
mechanism of Solanecio mannii aqueous roots extract against cervical cancer.
PLoS One. 2025;20:e0323680.
PubMed
Abstract available
Validity of the process and outcome specific measure in women with abnormal
Papanicolaou screening test.
PLoS One. 2025;20:e0325131.
PubMed
Abstract available
Bardoxolone methyl blocks the efflux of Zn2+ by targeting hZnT1 to inhibit the
proliferation and metastasis of cervical cancer.
Protein Cell. 2025 Jun 5:pwaf044. doi: 10.1093.
PubMed
Automatic cervical tumors segmentation in PET/MRI by parallel encoder U-net.
Radiat Oncol. 2025;20:95.
PubMed
Abstract available
Understanding the Influences of Cervical Screening Attendance among Women of Low
Socioeconomic Position Using the Integrated Screening Action Model: A Qualitative
Study.
Semin Oncol Nurs. 2025;41:151891.
PubMed
Abstract available
Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in
women with stage IB-IIB cervical cancer: Do we need to change the therapeutic
approach? A cohort study.
Surg Pract Sci. 2025;21:100284.
PubMed
Abstract available
Evaluation of lymph node metastasis in cervical cancer: A retrospective
comparison of preoperative MRI and PET/CT with postoperative histopathology
results.
Turk J Obstet Gynecol. 2025;22:129-133.
PubMed
Abstract available
Factors associated with HPV vaccine hesitancy: A nationally representative
cross-sectional study.
Vaccine. 2025;59:127278.
PubMed
Abstract available
"The only vaccine that we really question is the new vaccine": A qualitative
exploration of the social and behavioural drivers of human papillomavirus (HPV)
vaccination in Tonga.
Vaccine. 2025;59:127280.
PubMed
Abstract available
HPV genotyping agreement between paired cervical cytological sample and biopsy
across lesion severity and vaccination.
Virol J. 2025;22:176.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
